SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

59 hedge funds and large institutions have $27.5M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$700K
Puts
$1K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.67M
2
$3.94M
3
$2.65M
4
$2.42M
5
$2.35M
6
$2.05M
7
$1.93M
8
$1.3M
9
$710K
10
$671K
11
$665K
12
$502K
13
$325K
14
$281K
15
$222K
16
$222K
17
$209K
18
$147K
19
$132K
20
$122K
21
$88.5K
22
$81.6K
23
$80.7K
24
$71.2K
25
$61K